Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Seibold

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT IIChristian Mottet, John-Paul Vader, Christian Felley, et al.
Swiss Medical Weekly|June 14, 2024
Bone health in patients with inflammatory bowel diseaseAndrea S Kreienbuehl, Gerhard Rogler, Burri Emanuel, et al.
Digestion|August 29, 2019
Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based ConsensusThomas Greuter, Michel H Maillard, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|June 9, 2014
The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patientsMarijana Protic, Frank Seibold, Alain Schoepfer, et al.
Inflammatory Bowel Diseases|December 17, 2009
Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: results of the FACTS surveyAlain M Schoepfer, Stephan R Vavricka, Janek Binek, et al.
Autophagy|March 18, 2016
Activation of the EIF2AK4-EIF2A/eIF2α-ATF4 pathway triggers autophagy response to Crohn disease-associated adherent-invasive Escherichia coli infectionAlexis Bretin, Jessica Carrière, Guillaume Dalmasso, et al.
United European Gastroenterology Journal|September 9, 2024
Fecal urgency and incontinence in inflammatory bowel disease perceived by physician and patient: Results from the Swiss fecal urgency surveyNadia Wespi, Stephan Vavricka, Stephan Brand, et al.
European Journal of Gastroenterology & Hepatology|October 23, 2010
Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriatenessPascal Juillerat, Valérie Pittet, John-Paul Vader, et al.
Inflammatory Bowel Diseases|November 13, 2013
Periodontitis and gingivitis in inflammatory bowel disease: a case-control studyStephan R Vavricka, Christine N Manser, Sebastian Hediger, et al.
Scandinavian Journal of Gastroenterology|May 7, 2010
Variant alleles of the mannose binding lectin 2 gene (MBL2) confer heterozygote advantage within Crohn's familiesT P Velavan, Angelica B W Boldt, Jürgen Tomiuk, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT IIChristian Mottet, John-Paul Vader, Christian Felley, et al.
Swiss Medical Weekly|June 14, 2024
Bone health in patients with inflammatory bowel diseaseAndrea S Kreienbuehl, Gerhard Rogler, Burri Emanuel, et al.
Digestion|August 29, 2019
Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based ConsensusThomas Greuter, Michel H Maillard, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|June 9, 2014
The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patientsMarijana Protic, Frank Seibold, Alain Schoepfer, et al.
Inflammatory Bowel Diseases|December 17, 2009
Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: results of the FACTS surveyAlain M Schoepfer, Stephan R Vavricka, Janek Binek, et al.
Autophagy|March 18, 2016
Activation of the EIF2AK4-EIF2A/eIF2α-ATF4 pathway triggers autophagy response to Crohn disease-associated adherent-invasive Escherichia coli infectionAlexis Bretin, Jessica Carrière, Guillaume Dalmasso, et al.
United European Gastroenterology Journal|September 9, 2024
Fecal urgency and incontinence in inflammatory bowel disease perceived by physician and patient: Results from the Swiss fecal urgency surveyNadia Wespi, Stephan Vavricka, Stephan Brand, et al.
European Journal of Gastroenterology & Hepatology|October 23, 2010
Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriatenessPascal Juillerat, Valérie Pittet, John-Paul Vader, et al.
Inflammatory Bowel Diseases|November 13, 2013
Periodontitis and gingivitis in inflammatory bowel disease: a case-control studyStephan R Vavricka, Christine N Manser, Sebastian Hediger, et al.
Scandinavian Journal of Gastroenterology|May 7, 2010
Variant alleles of the mannose binding lectin 2 gene (MBL2) confer heterozygote advantage within Crohn's familiesT P Velavan, Angelica B W Boldt, Jürgen Tomiuk, et al.
Pageof 8